Results 11 to 20 of about 1,588,155 (297)

Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI–treated NSCLC: a cross-database real-world study [PDF]

Frontiers in Pharmacology
IntroductionEpidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have transformed the treatment of EGFR-mutant non–small-cell lung cancer (NSCLC), significantly improving survival outcomes and quality of life compared with conventional
Natalia Sauer, Piotr Giedziun, Jacek Calik, Anna Wiela-Hojeńska   +3 more
doaj   +2 more sources

Pharmacovigilance analysis of cutaneous adverse drug reactions for cetuximab, panitumumab, and necitumumab based on EudraVigilance and WHO VigiAccess [PDF]

Frontiers in Pharmacology
IntroductionAnti-EGFR monoclonal antibodies (mAbs)--cetuximab, panitumumab, and necitumumab--are cornerstone therapies for selected solid tumors but are frequently associated with cutaneous adverse drug reactions (ADRs).
Natalia Sauer, Piotr Giedziun, Jacek Calik, Jacek Calik, Anna Wiela-Hojeńska   +4 more
doaj   +2 more sources

Psoriasis and type 2 diabetes mellitus: epidemiology, shared mechanisms, and therapeutic implications: a narrative review [PDF]

Frontiers in Medicine
Psoriasis is a chronic immune-mediated inflammatory disorder increasingly recognized as a systemic disease rather than an isolated cutaneous condition. In addition to its dermatologic burden, psoriasis is associated with multiple metabolic comorbidities,
Amr Molla
doaj   +2 more sources

Immune checkpoint inhibitor-associated eosinophilic fasciitis: a systematic review of reported cases [PDF]

Anais Brasileiros de Dermatologia
Background Eosinophilic Fasciitis (EF) is a rare immune-mediated fibrosing disorder of the fascia. Immune Checkpoint Inhibitors (ICIs) have transformed oncologic therapy but may precipitate immune-related Adverse Events (irAEs), including dermatologic ...
Yahya Argobi, Faisal Tobeigei, Faris I. Alasiri   +2 more
doaj   +3 more sources

Targeted Agents: Management of Dermatologic Toxicities

Journal of the National Comprehensive Cancer Network, 2014
Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of many cancers, and the cutaneous toxicity profile associated with these agents has become prominent.
Barbara Burtness
core   +3 more sources

Comparative efficacy of hemostatic agents in dermatologic surgery: A systematic review

JAAD Reviews
This supplementary file contains the references included in the systematic review and meta-analysis titled “Comparative Efficacy and Safety of Hemostatic Agents in Dermatologic Surgery.” The study synthesized evidence from 12 comparative studies ...
Isabella Ribaudo, MD, Katelyn Vlastaris, BS, Michelle Bongiorno, MD, Mark Biro, MD, Pooja Rambhia, MD, Neil Nero, BA, Micah Belzberg, MD, Christine Poblete-Lopez, MD   +7 more
doaj   +2 more sources

First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?

JMIR Cancer, 2021
Cutaneous melanoma has always been a dreaded diagnosis because of its high mortality rate and its proclivity for invasiveness and metastasis.
Louay S Abdulkarim, Richard J Motley
doaj   +1 more source

Effect of combining Zingiber officinale and Juglans regia extracts on Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis: antibiofilm action and low toxicity

Anais da Academia Brasileira de Ciências, 2022
Objective was evaluated the therapeutic effect of Juglans regia (J) and Zingiber officinale (Z) extracts, alone or associated (Z75% + J25%, Z50% + J50% and Z25% + J75%) applied on planktonic cultures and biofilms of Propionibacterium acnes ...
LEONARDO A. DA SILVA, LUCAS P. RAMOS, TATIANE A. SILVA, SIMONE A.B. DE LAPENA, CARLOS EDUARDO R. SANTOS, AMJAD A. HASNA, ADRIANO BRESSANE, LUCIANE D. DE OLIVEIRA   +7 more
doaj   +1 more source

Novel antiangiogenic agents in dermatology [PDF]

Archives of Biochemistry and Biophysics, 2011
Because angiogenesis underlies the pathogenesis of numerous conditions (cancer, psoriasis, macular degeneration), there is a pressing need for continued investigations into angiogenic signaling and potential drug targets. Antiangiogenic agents can be classified as either direct or indirect.
Ricardo L, Berrios, Jack L, Arbiser
openaire   +2 more sources

Intralesional agents in dermatology: Pros and cons

Journal of Cutaneous and Aesthetic Surgery, 2021
Since introduced in 1961, intralesional (IL) agent has become an essential part of the dermatological practice. The term IL referred to the direct delivery of agent percutaneously into skin lesions. This therapeutic approach is relatively safe, easy to perform and applicable for a broad range of dermatological conditions.
Sakhiya, Jagdish, Sakhiya, Dhruv, Kaklotar, Jitesh, Hirapara, Bansi, Purohit, Madhav, Bhalala, Krishna, Daruwala, Feral, Dudhatra, Nimish   +7 more
openaire   +2 more sources